ODT’s Most-Read Stories This Week—Feb. 26

Personnel and products were the dominant forces this past week on ODT’s website.

Garnering the most page views was Smith+Nephew’s announcement of its new CEO, Dr. Deepak Nath. The former president of Diagnostics at Siemens Healthineers, Nath has held senior positions at Abbott Labs and eventually became president of Abbott Vascular, where he helped broker the company’s $28 billion deal for St. Jude Medical. Nath also worked for Amgen, McKinsey and Company and as a scientist at the Lawrence Livermore National Laboratory. He earned his bachelor and master’s of science degrees from the University of California, Berkeley. He succeeds current Smith+Nephew CEO Roland Digglemann and will officially begin his new job on April 1.    

Paragon 28’s two new board additions also drove website traffic, as did Hip Innovation Technologies’ pair of hires. Former Medtronic executives B. Kristine Johnson and Kristina Wright are now part of Paragon 28’s Board of Directors; Johnson worked at Medtronic from 1982 to 1999, and has been president and a general partner at Affinity Capital Management since 2000. Wright has served as vice president and chief financial officer for Medtronic’s Neuromodulation Operation Unit since July 2020. Last August, she was named interim general manager for the Brain Modulation business within Neuromodulation; Wright previously held various leadership positions at Medtronic in both finance and corporate development since August 2010.  

Hip Innovation Technologies, meanwhile, hired Steven MacDonald, M.D., as chief scientific officer, and Frank Maas as chief operations officer. MacDonald is an internationally recognized hip and knee replacement thought leader who currently is a professor and JC Kennedy chairman of Orthopaedic Surgery at the University of Western Ontario in London, Ontario, Canada. He has received more than 25 research grants for hip and knee replacement projects totaling over $5 million. Maas has more than 30 years of orthopedic, spine, and athroscopic executive experience. He most recently was senior vice president at Arthrex Inc., but he also worked for five years as director of Regulatory and Clinical Affairs at DePuy Spine, where he helped win FDA approval of the first artificial disc in the United States. Before DePuy, Maas worked for Howmedica/Stryker Orthopaedics for 10 years in both quality assurance and regulatory affairs positions. 

Non-personnel news driving website traffic this past week included Safe Orthopaedics’ development agreement with Brainlab (for navigable instrument technology), and the debut of Stryker’s new PROstep MICA SOLO all-in-one minimally invasive bunion procedure guide. 

1. Smith+Nephew Appoints Siemens Exec Dr. Deepak Nath as CEO
 

2. Safe Ortho, Brainlab Team Up to Develop Instrument Navigation
 

3. B. Kristine Johnson and Kristina Wright Join Paragon 28 Board 
 

4. Steven MacDonald, Frank Maas Join Hip Innovation Technology Leadership
 

5. Stryker Rolls Out PROstep MICA SOLO for MIS Bunion Surgeries